Therefore, we hypothesize that dysfunction of the SWI/SNF complex may have a potential impact on MAPK signaling, synergistically enhancing the anti-tumor effects of ALK inhibitors on tumor cell proliferation. Here, SMARCA1 is linked to neoplasm.